Fulgent Genetics (MEX:FLGT) Construction In Progress: MXN0 Mil (As of Mar. 2026)


MEX:FLGT Fulgent Genetics Inc MEX:FLGT
47 GF Score
Price MXN372.00
GF Value MXN730.74
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Fulgent Genetics Construction In Progress?

Fulgent Genetics MEX:FLGT +19.04% 47 Construction In Progress is MXN0 Mil as of Mar. 2026. GuruFocus rates MEX:FLGT with a GF Score™ of 47/100 and a GF Value™ of MXN730.74 (Possible Value Trap). The stock has 4 warning signs investors should review.

Fulgent Genetics Construction In Progress Historical Data

* Premium members only.

The historical data trend for Fulgent Genetics's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fulgent Genetics Construction In Progress Chart

Fulgent Genetics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Fulgent Genetics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
MEX:FLGT
47GF Score
Fulgent Genetics Inc MEX:FLGT
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fulgent Genetics Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of MXN0 Mil mean?
Fulgent Genetics (MEX:FLGT) has a Construction In Progress of MXN0 Mil as of Mar. 2026. Construction in Progress records the amount of construction work that is not complete. View historical data on Fulgent Genetics and its competitors.
Is Fulgent Genetics' Construction In Progress too high?
Fulgent Genetics' current Construction In Progress is MXN0 Mil. Overall, Fulgent Genetics has a GF Score™ of 47/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Fulgent Genetics' Construction In Progress compare to MYGN and CSTL?
Fulgent Genetics' Construction In Progress of MXN0 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Medical Diagnostics & Research company?
A good Construction In Progress depends on the Medical Diagnostics & Research industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on Fulgent Genetics and its competitors. Fulgent Genetics's current Construction In Progress is MXN0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fulgent Genetics stock overvalued right now?
Based on GuruFocus' analysis, Fulgent Genetics (MEX:FLGT) is currently considered Possible Value Trap. The stock's GF Value™ is MXN730.74, compared to a current price of MXN372.00 — trading 49.1% below its estimated fair value. The current Construction In Progress is MXN0 Mil. Fulgent Genetics' overall GF Score™ is 47/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For Fulgent Genetics (MEX:FLGT), the current Construction In Progress is MXN0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fulgent Genetics (MEX:FLGT) Overvalued in 2026?

Based on GuruFocus' analysis, Fulgent Genetics stock appears to be undervalued. The current stock price of MXN372.00 is trading 49.1% below its estimated GF Value™ of MXN730.74. GuruFocus considers Fulgent Genetics to be Possible Value Trap.

Key valuation signals for MEX:FLGT:

  • Construction In Progress: MXN0 Mil
  • GF Value™: MXN730.74 vs. price of MXN372.00 (49.1% below fair value)
  • GF Score™: 47/100 with 4 warning signs

No single metric tells the full story. See the MEX:FLGT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fulgent Genetics Business Description

Other Exchanges FLGT:USA
Address 4399 Santa Anita Avenue, El Monte, CA, USA, 91731
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in the laboratory services business and the therapeutic development business. The laboratory services business, which generates key revenue, includes technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue, and Foreign.
47GF Score

Get the complete analysis for MEX:FLGT

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN372.00
Price
MXN730.74
GF Value